Active ingredient
Moexipril
6 finished FDA listings contain Moexipril as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- MOEXIPRIL HYDROCHLORIDE
- Dosage forms
- Tablet, Film Coated
- Routes
- Oral
- Manufacturers / labelers
- 3
- Strengths listed
- 15 mg/1 · 7.5 mg/1
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 30131
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| ANDA 076204 | TEVA | 2003-05-08 | 2 |
| ANDA 077536 | CHARTWELL RX | 2006-11-30 | 2 |
| ANDA 090416 | GLENMARK PHARMS LTD | 2010-03-30 | 2 |
Official labeling on DailyMed
- MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] · version 12 · 2026-01-26
- MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA, INC.] · version 11 · 2025-09-18
- MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CHARTWELL RX, LLC] · version 1 · 2025-03-12
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.